Drug name - Sancuso

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7608282 KYOWA KIRIN Transdermal granisetron Jan, 2025

(2 years from now)

Drugs and Companies using GRANISETRON ingredient

Treatment: Use of granisetron transdermal system to treat/prevent chemotherapy induced nausea and vomiting

Dosage: FILM, EXTENDED RELEASE;TRANSDERMAL

More Information on Dosage
Strength Dosage Availability
3.1MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.